(2S,3S,4R,5S,6S)-2-[(2R,3R,4S,5R,6R)-2-[(3R,4R,5S,6R)-3-Amino-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol

Term ID

CHEBI:154513

Synonyms

6-deoxy-alpha-L-galacto-hexopyranosyl-(1->2)-beta-D-galacto-hexopyranosyl-(1->3)-2-amino-2-deoxy-D-gluco-hexopyranose
Fuc(a1-2)Gal(b1-3)GlcN

Definition

References

glygen:G89032VF
glytoucan:G89032VF

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (2S,3S,4R,5S,6S)-2-[(2R,3R,4S,5R,6R)-2-[(3R,4R,5S,6R)-3-Amino-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol

Phenotype where environments contain (2S,3S,4R,5S,6S)-2-[(2R,3R,4S,5R,6R)-2-[(3R,4R,5S,6R)-3-Amino-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol

Phenotype modified by environments containing (2S,3S,4R,5S,6S)-2-[(2R,3R,4S,5R,6R)-2-[(3R,4R,5S,6R)-3-Amino-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol

Phenotype affecting (2S,3S,4R,5S,6S)-2-[(2R,3R,4S,5R,6R)-2-[(3R,4R,5S,6R)-3-Amino-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol

Human Disease Model